Cargando…
Protocol for genome-scale in vivo CRISPR screening to study protection of beta cells under autoimmunity in a type 1 diabetes mouse model
Autoimmunity-induced pancreatic beta cell failure is the main characteristic of type 1 diabetes (T1D). Here, we describe a protocol for genome-scale in vivo CRISPR-Cas9 screening for use in a mouse model of T1D. Using a non-obese-diabetic-derived mouse beta cell line, NIT-1, and a genome-wide CRISPR...
Autores principales: | Li, Jian, Lee, Yu-Chi, Iessi, Isabela L., Wu, Chialing, Yi, Peng, Cai, Erica P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025263/ https://www.ncbi.nlm.nih.gov/pubmed/36917606 http://dx.doi.org/10.1016/j.xpro.2023.102155 |
Ejemplares similares
-
Genome scale in vivo CRISPR screen identifies RNLS as a target for beta cell protection in type 1 diabetes
por: Cai, Erica P., et al.
Publicado: (2020) -
CRISPR screen to determine the in vivo fitness of Toxoplasma genes
por: Sangaré, Lamba Omar, et al.
Publicado: (2021) -
Protocol for in vivo CRISPR screening using selective CRISPR antigen removal lentiviral vectors
por: Lane-Reticker, Sarah Kate, et al.
Publicado: (2023) -
Genome-scale chemogenomic CRISPR screens in human cells using the TKOv3 library
por: Olivieri, Michele, et al.
Publicado: (2021) -
Optimized protocols for efficient gene editing in mouse hepatocytes in vivo using CRISPR-Cas9 technology
por: Chen, Yanhao, et al.
Publicado: (2021)